Travis Mickle
Chairman at KemPharm Denmark A/S
Net worth: 254 110 $ as of 2024-04-29
Travis Mickle active positions
| Companies | Position | Start | End |
|---|---|---|---|
KemPharm Denmark A/S
 KemPharm Denmark A/S Miscellaneous Commercial ServicesCommercial Services Part of Zevra Therapeutics, Inc., KemPharm Denmark A/S is a Danish company that engages in the development of novel treatments for central nervous system. The company is based in Copenhagen, Denmark. The company was founded in 2022. The CEO is Raymond la Duane Clifton. | Chairman | 2022-05-12 | - |
Career history of Travis Mickle
Former positions of Travis Mickle
| Companies | Position | Start | End |
|---|---|---|---|
| ZEVRA THERAPEUTICS, INC. | Director/Board Member | 2021-11-04 | 2023-04-24 |
| Chief Executive Officer | 2010-09-30 | 2023-04-24 | |
| Chairman | 2014-10-31 | 2021-11-04 | |
| Chief Tech/Sci/R&D Officer | 2006-10-29 | 2010-09-30 | |
| Founder | 2006-10-29 | 2023-04-24 | |
| President | 2006-10-29 | 2023-04-24 | |
New River Pharmaceuticals, Inc.
 New River Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology New River Pharmaceuticals, Inc. develops pharmaceutical products. Its product candidates in clinical development are an amphetamine derivative (NDA filed) and an opioid derivative that they believe will provide alternatives to marketed drugs. The company was founded by Randal J. Kirk in 1996 and is headquartered in Radford, VA. | Corporate Officer/Principal | 2001-12-31 | 2005-09-30 |
Training of Travis Mickle
| Simpson College | Undergraduate Degree |
| University of Iowa | Doctorate Degree |
Statistics
International
| United States | 5 |
| Denmark | 2 |
Operational
| Chairman | 2 |
| Director/Board Member | 1 |
| Chief Executive Officer | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| ZEVRA THERAPEUTICS, INC. | Health Technology |
| Private companies | 2 |
|---|---|
New River Pharmaceuticals, Inc.
New River Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology New River Pharmaceuticals, Inc. develops pharmaceutical products. Its product candidates in clinical development are an amphetamine derivative (NDA filed) and an opioid derivative that they believe will provide alternatives to marketed drugs. The company was founded by Randal J. Kirk in 1996 and is headquartered in Radford, VA. | Health Technology |
KemPharm Denmark A/S
KemPharm Denmark A/S Miscellaneous Commercial ServicesCommercial Services Part of Zevra Therapeutics, Inc., KemPharm Denmark A/S is a Danish company that engages in the development of novel treatments for central nervous system. The company is based in Copenhagen, Denmark. The company was founded in 2022. The CEO is Raymond la Duane Clifton. | Commercial Services |
- Stock Market
- Insiders
- Travis Mickle
- Experience
